Sansure Biotech Inc (688289) — Financial Flexibility Index
Sansure Biotech Inc (688289) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥122.80 Million (operating CF CN¥59.72 Million minus capex CN¥63.08 Million) represents 0% of total liabilities (CN¥2.24 Billion). Check Sansure Biotech Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sansure Biotech Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Sansure Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see 688289 cash flow conversion.
Annual Financial Flexibility Index for Sansure Biotech Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Sansure Biotech Inc. Explore Sansure Biotech Inc (688289) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥695.55 Million | CN¥274.45 Million | CN¥1.26 Billion | ▲ +12.9% |
| 2023 | 0.49x | CN¥504.17 Million | CN¥112.82 Million | CN¥1.03 Billion | ▼ -73.9% |
| 2022 | 1.88x | CN¥3.12 Billion | CN¥2.56 Billion | CN¥1.66 Billion | ▼ -40.8% |
| 2021 | 3.17x | CN¥2.25 Billion | CN¥1.88 Billion | CN¥709.03 Million | ▼ -18.2% |
| 2020 | 3.88x | CN¥2.75 Billion | CN¥2.64 Billion | CN¥708.95 Million | ▲ +483.2% |
| 2019 | 0.67x | CN¥56.55 Million | CN¥22.41 Million | CN¥84.99 Million | ▲ +141.2% |
| 2018 | 0.28x | CN¥42.97 Million | CN¥10.07 Million | CN¥155.76 Million | ▲ +226.3% |
| 2017 | -0.22x | CN¥-40.76 Million | CN¥-61.44 Million | CN¥186.62 Million | — |